INSMED Inc (INSM) is a pharmaceutical preparations company incorporated in VA, listed on the Nasdaq. With a market capitalization of $31.2 billion, INSMED Inc is a large-cap company. The stock currently trades at $146.32, down 2.02% today, with a 52-week range of $60.40–$212.75. The company trades at a forward P/E of 394.7x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-6.42 | $-6.42 | -15.3% | |
| 2024 | $-5.57 | $-5.57 | -4.3% | |
| 2023 | $-5.34 | $-5.34 | -36.6% | |
| 2022 | $-3.91 | $-3.91 | -0.8% | |
| 2021 | $-3.88 | $-3.88 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | $-2.95 | $-2.95 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-19 | 0001104506-26-000009 | SEC ↗ |
| 2024-12-31 | 2025-02-20 | 0001104506-25-000009 | SEC ↗ |
| 2023-12-31 | 2024-02-22 | 0001104506-24-000008 | SEC ↗ |
| 2022-12-31 | 2023-02-23 | 0001104506-23-000009 | SEC ↗ |
| 2021-12-31 | 2022-02-17 | 0001104506-22-000008 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0001104506-21-000005 | SEC ↗ |
| 2019-12-31 | 2020-02-25 | 0001104506-20-000007 | SEC ↗ |
| 2018-12-31 | 2019-02-22 | 0001104506-19-000009 | SEC ↗ |
| 2017-12-31 | 2018-02-23 | 0001104506-18-000002 | SEC ↗ |
| 2016-12-31 | 2017-02-23 | 0001047469-17-000856 | SEC ↗ |
| 2015-12-31 | 2016-02-25 | 0001047469-16-010395 | SEC ↗ |